Blood clot drug tested in kids, but study ends early

NCT ID NCT05966740

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 25 times

Summary

This study looked at the safety and effectiveness of Pradaxa Pellets, a blood thinner, for children aged 3 months to under 12 years who had or were at risk of blood clots. Only 6 children were enrolled before the study was stopped early. The goal was to track bleeding events and whether clots returned, but results are limited due to the small number of participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cincinnati Children's Hospital

    Cincinnati, Ohio, 45229, United States

  • Dayton Children's Hospital

    Dayton, Ohio, 45404, United States

  • Dell Children's Ascension

    Austin, Texas, 78723, United States

  • Indiana Hemophilia & Thrombrosis Center

    Indianapolis, Indiana, 46260, United States

  • Johns Hopkins All Children's Hospital

    St. Petersburg, Florida, 33701, United States

  • MUSC (Medical university of South Carolina)

    Charleston, South Carolina, 29425, United States

  • Rady Children's Hospital

    San Diego, California, 92123, United States

  • University of California, San Diego

    La Jolla, California, 92093, United States

  • Vanderbilt University

    Nashville, Tennessee, 37232, United States

  • Yale University School of Medicine

    New Haven, Connecticut, 06519, United States

Conditions

Explore the condition pages connected to this study.